Key information

Application number
202612370
Trademark text
ZEGFROVY
Case type
National mark
Status
23.10.2026 Uten forutgående uttalelse
Filed
09.10.2026
Registration number
343930
Registered
23.10.2026
Published in the Gazette
26.10.2026
Opposition deadline
26.01.2027
Grace period start date, cf. Trademarks Act Section 37
27.01.2027
Renewal deadline
09.10.2036
Trademark category
Trademark
Type of Mark
Word Mark
Goods/services (NICE class)
5
Acquired distinctiveness
No
Applicant
AstraZeneca UK Limited (GB)
Owner
AstraZeneca UK Limited (GB)
Agent
NORSK PATENTBYRÅ AS (NO)

List of products

Class 5
Farmasøytiske preparater og substanser.

Documents

 Download files (4)
Date
 Date Doc. No. Process Case number In/Out Journal description To/from
 23.10.2026 03-01 Saksbehandling 202612370 UT Oversendelse reg. brev (VM202612370) NORSK PATENTBYRÅ AS
 13.10.2026 02-02 Saksbehandling 202612370 INN 3475_001 NORSK PATENTBYRÅ AS
 13.10.2026 02-01 Saksbehandling 202612370 INN Korrespondanse (Hovedbrev inn) NORSK PATENTBYRÅ AS
 09.10.2026 01-01 Saksbehandling 202612370 INN Søknadsskjema Varemerke NORSK PATENTBYRÅ AS

Priority

No priority

Applicants and owners

Owners
AstraZeneca UK Limited
1 Francis Crick Avenue, Cambridge Biomedical Campus CB20AA CAMBRIDGE GB

Agent

NORSK PATENTBYRÅ AS
NORSK PATENTBYRÅ AS

Org. number: 877071022

Name and address are automatically synchronized with the Brønnøysund Register Centre.

Open in The Brønnøysund Register Centre
Henrik Ibsens gate 90 0255 OSLO NO (OSLO Municipality, Oslo county)
Org. number: 877071022
Reference: 22868/NO

Status history

Payment history

Oppositions and appeals

No oppositions or appeals

Alteration of mark

No alteration of mark

Liens and licences

No liens or licenses registered

Gazette entries

No Gazette entries foundOnly events from 2024.03.04 and onwards are shown.